Laurel Menapace

The role of thromboprophylaxis in cancer patients: emerging data

A. Khorana, L. Menapace, Laurel Menapace, 2010, Current opinion in hematology.

Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer

Derick R. Peterson, A. Khorana, D. Peterson, 2011, Thrombosis and Haemostasis.

A Phase 1 Dose Escalation Study of the Pyruvate Kinase Activator Mitapivat (AG-348) in Sickle Cell Disease.

W. Eaton, C. Kung, L. Dang, 2022, Blood.

Predictors of recurrent venous thromboembolism and bleeding on anticoagulation.

A. Khorana, K. McCrae, L. Menapace, 2016, Thrombosis research.

Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.

A. Khorana, C. Francis, G. Connolly, 2013, Clinical lung cancer.

Global Variation in Opioid Use in Prostate Cancer Trials.

R. Pazdur, J. Roydhouse, G. Blumenthal, 2019, JAMA Oncology.

Mitapivat (AG-348) Demonstrates Safety, Tolerability, and Improvements in Anemia, Hemolysis, Oxygen Affinity, and Hemoglobin S Polymerization Kinetics in Adults with Sickle Cell Disease: A Phase 1 Dose Escalation Study

W. Eaton, C. Kung, L. Dang, 2021, Blood.